Abstract:One of the important directions in AD research is developing widely accessible surrogate markers that could detect AD brain pathology at the clinically silent preclinical stages. Our approach relies on the MRI-based Gradient Echo Plural Contrast Imaging (GEPCI) technique that provides in vivo quantitative high resolution 3D measurements of several brain-tissue-specific relaxation properties (GEPCI metrics) of the gradient recalled echo (GRE) MRI signal. Since GEPCI metrics depend on the molecular constituents present in the brain they can serve as surrogate markers of tissue alterations that reflect the integrity of brain cellular structure and disease-related tissue damage. 34 participants (ranging from normal, to preclinical, to mild AD) selected from the studies of aging and dementia at the Knight Alzheimer's Disease Research Center at Washington University underwent GEPCI MRI (Siemens 3T) and a collection of cognitive performance tests. PET PiB data were available for 19 participants. Our data show that AD brain pathology can be characterized by two GEPCI metrics: total (R2*) relaxation rate constant, sensitive to amyloid-β (Aβ) accumulation, and tissue specific (R2t*) relaxation rate constant, sensitive to alterations in tissue cellular structure. We found that (i) The accumulation of Aβ leads to increased R2* values and this increase can be used as a surrogate measure of Aβ that strongly correlates with PET measurements (e.g. r= 0.61,0.68, 0.84 in precuneus, paracentral and parahippocampal cortices); (ii) The neuronal loss leads to decreased GEPCI R2t* values and the magnitude of this decrease can be used as a surrogate measure of neuronal loss (Fig.1); (iii) Decreased GEPCI R2t* in the hippocampus demonstrated much stronger correlations with psychometric tests than hippocampal atrophy (Fig.2) suggesting higher GEPCI R2t* sensitivity to tissue neuronal loss as compared to volumetric measurements. (iv) GEPCI metrics demonstrated significant differences between normal and preclinical, normal and mild AD, and preclinical and mild AD groups. GEPCI in vivo measurements obtained on a clinical MRI provide information on brain AD-related pathology in human participants. Since MRI is a widely-available technology, the GEPCI technique has great potential for widespread use in tracking early brain pathology and evaluation of new disease-modifying therapies. An 81 year old male study participant with a clinical diagnosis of AD dementia (CDR 1) who underwent MRI 11 months prior to expiration. (A) MPRAGE image, (B) GEPCI R2t* map. GEPCI R2t* in the hippocampus (outlined in yellow, segmented based on FreeSurfer) shows hypointense lesions (reduced R2t* values) consistent with the loss of cellular integrity even in the remaining part of hippocampus, thus suggesting higher sensitivity of GEPCI R2t* measurements to tissue neuronal loss as compared to standard volumetric measurements. This is confirmed by direct neuropathological examination shown in panel C (hippocampal area), obtained from the postmortem studies from this participant. Severe neuronal loss (hematoxylin and eosin stain) is indicated by the only present neuron on this image (indicated by the arrow). Also shown (panel D) is an example from hippocampus of a 79-year-old female with Alzheimer disease showing preservation of many neurons. Scale bars are 0.1 mm. Correlation between cognition and hippocampal R2t* (upper panel). Cognitive measures included Free and Cued Selective Reminding Test (Srtfree), Animal Naming (ANIMALS), and Trail making Test Part A completion time (Tma). Note that higher scores on Tma indicate worse performance. Correlations with hippocampal volume are also presented for comparison (lower panel). Each point represents a single participant (n = 34). Shaded areas represent 95% confidence intervals of linear fits (solid lines). Pearson correlation coefficients (r) and p values are shown in the left upper corners.

On the Relationship Between Cellular and Hemodynamic Properties of the Human Brain Cortex Throughout Adult Lifespan.

Age- and Time-of-day Dependence of Glymphatic Function in the Human Brain Measured Via Two Diffusion MRI Methods.

Genetically Defined Cellular Correlates of the Baseline Brain MRI Signal.

Relaxation time of brain tissue in the elderly assessed by synthetic MRI

GRADIENT ECHO PLURAL CONTRAST MRI PROVIDES NEW SURROGATE MARKERS OF BRAIN PATHOLOGY IN ALZHEIMER’S DISEASE

Different Grey Matter Microstructural Patterns in Cognitively Healthy Versus Typical Ageing Healthy Versus Typical Brain Ageing

Aging and the Spectral Properties of Brain Hemodynamics

Coupling Between Human Brain Cortical Thickness and Glucose Metabolism from Regional to Connective Level: A Positron Emission Tomography/Magnetic Resonance Imaging Study.

Coupling between Human Brain Cortical Thickness and Glucose Metabolism from Regional to Connective level: a PET/MRI study

The Relationship Between Cerebral Glucose Metabolism and Age: Report of A Large Brain Pet Data Set

Evidence of An Association Between Cerebral Blood Flow and Microstructural Integrity in Normative Aging Using a Holistic MRI Approach

Unique information from common diffusion MRI models about white-matter differences across the human adult lifespan

Complexity analysis of heartbeat-related signals in brain MRI time series as a potential biomarker for ageing and cognitive performance

Age‐Related Differences of Cortical Topology Across the Adult Lifespan: Evidence From a Multisite MRI Study With 1427 Individuals

Healthy Aging: an Automatic Analysis of Global and Regional Morphological Alterations of Human Brain

Normative trajectories of R1, R2* and magnetic susceptibility in basal ganglia on healthy ageing

Global effects of aging on the hemodynamic response function in the human brain

Abstract 63: Age-related Changes In Gray Matter Cerebral Metabolism And Vascular Reactivity In Children

Changes in the intracellular microenvironment in the aging human brain

Revealing the spatial pattern of brain hemodynamic sensitivity to healthy aging through sparse DCM

Neuronal microstructural changes in the human brain are associated with neurocognitive aging